Last reviewed · How we verify

NCT06320964: TARANGPilot

The TARANG Intervention

Completed NA Results posted Last updated 6 February 2025
What this trial tests

NA trial testing TARANG in Feasibility in 42 participants. Completed in 21 January 2024.

Timeline
14 July 2023
Primary endpoint
21 January 2024
21 January 2024

Quick facts

Lead sponsorUniversity of California, San Francisco
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeprevention
Enrollment42
Start date14 July 2023
Primary completion21 January 2024
Estimated completion21 January 2024
Sites1 location across India

Drugs / interventions tested

Conditions studied

Sponsor

University of California, San Francisco

Who can join

18 and older, any sex, with Feasibility or Acceptability. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Feasibility of the Intervention Primary · Post-intervention at 5 month endline survey

Proportion of participants who complete 50% of the intervention sessions

GroupValue95% CI
TARANG Arm28
Acceptability Primary · Post-intervention at 5 month endline survey

Proportion of participants who were completely or somewhat satisfied with the intervention

GroupValue95% CI
TARANG Arm34
Usefulness Primary · Post-intervention at 5 month endline survey

Proportion of participants who found the TARANG intervention sessions very useful or somewhat useful

GroupValue95% CI
TARANG Arm35

Sponsor's own description

The mixed methods pilot study aims to evaluate the acceptability, feasibility, and implementation challenges of the TARANG intervention in villages in rural/tribal Rajasthan to inform the study design and operational details for a larger cluster-randomized controlled trial.

Publications & conference data

5 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Individual empowerment and community norm effects of engaging young husbands in reproductive health in rural India: findings from a pilot study.
    Diamond-Smith N, Vaishnav Y, Choudhary U, Sharma P, et al · · 2024 · cited 2× · PMID 39420379 · DOI 10.1186/s12978-024-01878-y
  2. Feasibility and acceptability of a life skills and reproductive health empowerment intervention for young newly married women in Rajasthan, India: a pre-post convergent mixed methods pilot study.
    Gopalakrishnan L, Patil S, Das D, Paul A, et al · · 2025 · cited 1× · PMID 41241746 · DOI 10.1186/s40814-025-01720-7
  3. Implementation and evaluation of a family planning intervention engaging mothers-in-law of young women in India: a mixed methods pilot study.
    Gopalakrishnan L, Choudhary U, Vallin J, Das D, et al · · 2025 · PMID 40916629 · DOI 10.1080/16549716.2025.2554435
  4. Feasibility and acceptability of a life skills and reproductive health empowerment interventionfor young newly married women in Rajasthan, India: A pre-post convergent mixed methods pilot study.
    Gopalakrishnan L, Patil S, Das D, Paul A, et al · · 2024 · DOI 10.21203/rs.3.rs-4255712/v1
  5. Individual empowerment and community norm effects of engaging young husbands in reproductive health in rural India: findings from a pilot study
    Diamond-Smith N, Vaishnav Y, Choudhary U, Sharma P, et al · · 2024 · DOI 10.21203/rs.3.rs-4376443/v1

Verify or expand the search:

Other trials of TARANG

Trials testing the same drug.

Other recruiting trials for Feasibility

Currently open trials in the same condition.

Other University of California, San Francisco trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06320964.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing